VBI Vaccines Inc/BC financial data

Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2024 - 15 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 56% % -75%
Quick Ratio 13% % -22%
Return On Equity -1082% % -574%
Return On Assets -94% % -24%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28,432,275 shares -89%
Common Stock, Shares, Outstanding 25,236,766 shares 193%
Common Stock, Value, Issued $455,057,000 USD 2.9%
Weighted Average Number of Shares Outstanding, Basic 24,584,798 shares 186%
Weighted Average Number of Shares Outstanding, Diluted 24,584,798 shares 186%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $9,411,000 USD 553%
Research and Development Expense $8,763,000 USD -46%
Operating Income (Loss) $72,154,000 USD 16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $82,985,000 USD 31%
Net Income (Loss) Attributable to Parent $82,985,000 USD 31%
Earnings Per Share, Basic -4 USD/shares -197%
Earnings Per Share, Diluted -4 USD/shares 77%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $227,000 USD -19%
Inventory, Net $9,944,000 USD 47%
Other Assets, Current $1,994,000 USD 0.91%
Assets, Current $26,361,000 USD -49%
Property, Plant and Equipment, Net $9,088,000 USD -22%
Operating Lease, Right-of-Use Asset $1,947,000 USD -35%
Intangible Assets, Net (Excluding Goodwill) $35,734,000 USD -39%
Goodwill $1,107,000 USD -48%
Other Assets, Noncurrent $1,206,000 USD -8%
Assets $75,443,000 USD -41%
Accounts Payable, Current $8,871,000 USD -9.8%
Employee-related Liabilities, Current $1,972,000 USD -22%
Contract with Customer, Liability, Current $9,619,000 USD 1382%
Liabilities, Current $77,594,000 USD 162%
Contract with Customer, Liability, Noncurrent $1,608,000 USD -18%
Operating Lease, Liability, Noncurrent $1,136,000 USD -44%
Accumulated Other Comprehensive Income (Loss), Net of Tax $31,811,000 USD 13%
Retained Earnings (Accumulated Deficit) $600,345,000 USD -16%
Stockholders' Equity Attributable to Parent $5,467,000 USD -112%
Liabilities and Equity $75,443,000 USD -41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $11,770,000 USD 46%
Net Cash Provided by (Used in) Financing Activities $843,000 USD
Net Cash Provided by (Used in) Investing Activities $151,000 USD 72%
Common Stock, Shares, Issued 25,236,766 shares 193%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $11,090,000 USD 50%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,565,000 USD 8.9%
Operating Lease, Liability $1,967,000 USD -35%
Payments to Acquire Property, Plant, and Equipment $151,000 USD -72%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $79,213,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid $2,243,000 USD -38%
Operating Lease, Liability, Current $831,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Two $584,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year One $663,000 USD -44%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure -7.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $276,000 USD -54%
Lessee, Operating Lease, Liability, to be Paid, Year Three $160,000 USD -73%
Depreciation, Depletion and Amortization $493,000 USD -3%
Interest Expense $6,790,000 USD 51%